NVO stock

Novo Nordisk A/S (NVO) Stock Today: Akero Deal, GLP‑1 Competition and Analyst Downgrades – What 10 December 2025 Means for Investors

Novo Nordisk stock is having a very noisy December 10, 2025. American depositary shares of Novo Nordisk A/S (ticker NVO) recently traded around $48 in New York, up roughly 3–4% intraday, with the session range hovering between about $47 and

10 December 2025

NVO Stock Today: Novo Nordisk Rebounds on New Weight‑Loss Drug Data After Alzheimer’s Blow (Nov. 25, 2025)

Key takeaways NVO stock today: price and trading snapshot (Nov. 25, 2025) As of late‑afternoon trading on Tuesday, November 25, 2025, Novo Nordisk A/S American Depositary Receipts (ADR), ticker NVO on the NYSE, were changing hands at about $47.08, up

25 November 2025

Drug Research · Novo Nordisk · Pharmaceuticals · Stock Market · Weight Loss

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

NVO Stock Today (Nov 6, 2025): Novo Nordisk volatile as White House pricing deal reshapes GLP‑1 market—what it means for Wegovy, Ozempic and investors

Published: November 6, 2025 TL;DR: Novo Nordisk’s U.S.‑listed shares (NYSE: NVO) swung after the White House announced a pricing-and-access deal with Novo and Eli Lilly that expands Medicare coverage for anti‑obesity drugs and cuts out‑of‑pocket costs. As of 17:51 UTC

6 November 2025

GLP‑1 Drugs · Healthcare Policy · Investment Analysis · NYSE:LLY · NYSE:NVO · Pharmaceuticals · Stock Market